Instil Bio (TIL)
(Delayed Data from NSDQ)
$12.65 USD
-0.22 (-1.71%)
Updated Aug 28, 2024 03:59 PM ET
After-Market: $12.26 -0.39 (-3.08%) 7:38 PM ET
3-Hold of 5 3
F Value A Growth C Momentum C VGM
Income Statements
Fiscal Year end for Instil Bio, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 0 | 0 | 0 | 0 | 0 |
Cost Of Goods | 0 | 0 | 0 | 0 | 0 |
Gross Profit | 0 | 0 | 0 | 0 | 0 |
Selling & Adminstrative & Depr. & Amort Expenses | 159 | 226 | 156 | 34 | 7 |
Income After Depreciation & Amortization | -159 | -226 | -156 | -34 | -7 |
Non-Operating Income | 8 | 3 | -1 | -4 | 0 |
Interest Expense | 5 | 2 | 0 | 0 | 0 |
Pretax Income | -156 | -225 | -157 | -38 | -7 |
Income Taxes | 0 | -2 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -156 | -223 | -157 | -38 | -7 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -156 | -223 | -157 | -38 | -7 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -154 | -205 | -153 | -33 | -7 |
Depreciation & Amortization (Cash Flow) | 5 | 22 | 3 | 0 | 0 |
Income After Depreciation & Amortization | -159 | -226 | -156 | -34 | -7 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 6.50 | 6.48 | 5.30 | NA | NA |
Diluted EPS Before Non-Recurring Items | -24.00 | -34.40 | -29.60 | NA | NA |
Diluted Net EPS (GAAP) | -24.00 | -34.40 | -29.60 | -47.20 | NA |
Fiscal Year end for Instil Bio, Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Cost Of Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A, R&D, and Dept/Amort Expenses | 14.13 | 23.96 | 13.02 | 66.71 | 20.99 |
Income After SG&A, R&D, and Dept/Amort Expenses | -14.13 | -23.96 | -13.02 | -66.71 | -20.99 |
Non-Operating Income | 1.22 | 1.63 | 2.08 | 1.29 | 2.92 |
Interest Expense | 2.00 | 1.98 | 1.98 | 2.00 | 0.59 |
Pretax Income | -14.92 | -24.30 | -12.93 | -67.43 | -18.66 |
Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -14.92 | -24.30 | -12.93 | -67.43 | -18.66 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -14.92 | -24.30 | -12.93 | -67.43 | -18.66 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 6.50 | 6.50 | 6.50 | 6.50 | 6.50 |
Diluted EPS Before Non-Recurring Items | -2.29 | -3.74 | -1.99 | -10.40 | -2.80 |
Diluted Net EPS (GAAP) | -2.29 | -3.74 | -2.00 | -10.40 | -2.80 |